2852 related articles for article (PubMed ID: 11351344)
21. Prostatic intraepithelial neoplasia occurs spontaneously in the canine prostate.
Waters DJ; Bostwick DG
J Urol; 1997 Feb; 157(2):713-6. PubMed ID: 8996404
[TBL] [Abstract][Full Text] [Related]
22. Ultrastructural changes in prostate cells during hormone-induced canine prostatic hyperplasia.
Gallardo-Arrieta F; Mogas T; Magán L; García MA; García F; Abal M; Morote J; Serrano S; Reventós J; Lioreta J
Ultrastruct Pathol; 2006; 30(6):435-42. PubMed ID: 17182436
[TBL] [Abstract][Full Text] [Related]
23. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal.
Walensky LD; Coffey DS; Chen TH; Wu TC; Pasternack GR
Cancer Res; 1993 Oct; 53(19):4720-6. PubMed ID: 7691403
[TBL] [Abstract][Full Text] [Related]
24. The distribution of oestrogen receptors in normal, hyperplastic and neoplastic canine prostate, as demonstrated immunohistochemically.
Grieco V; Riccardi E; Rondena M; Romussi S; Stefanello D; Finazzi M
J Comp Pathol; 2006 Jul; 135(1):11-6. PubMed ID: 16815431
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-dependent induction of cyclooxygenase-2 in the canine prostate in vivo.
Doré M; Chevalier S; Sirois J
Vet Pathol; 2005 Jan; 42(1):100-3. PubMed ID: 15657282
[TBL] [Abstract][Full Text] [Related]
26. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
27. Androgen ablation promotes neuroendocrine cell differentiation in dog and human prostate.
Ismail A HR; Landry F; Aprikian AG; Chevalier S
Prostate; 2002 May; 51(2):117-25. PubMed ID: 11948966
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
29. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
Yatkin E; Bernoulli J; Talvitie EM; Santti R
Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
Bonkhoff H; Stein U; Aumüller G; Remberger K
Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
[TBL] [Abstract][Full Text] [Related]
31. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
[TBL] [Abstract][Full Text] [Related]
32. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor content of the normal and hyperplastic canine prostate.
Shain SA; Boesel RW
J Clin Invest; 1978 Mar; 61(3):654-60. PubMed ID: 76635
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
35. Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate.
Tunn UW; Schüring B; Senge T; Neumann F; Schweikert HU; Rohr HP
Invest Urol; 1981 Jan; 18(4):289-92. PubMed ID: 6161104
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemistry of the prostate and prostate carcinomas].
Wernert N
Veroff Pathol; 1991; 135():1-163. PubMed ID: 2038892
[TBL] [Abstract][Full Text] [Related]
37. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
[TBL] [Abstract][Full Text] [Related]
38. Negative controls of cell proliferation: human prostate cancer cells and androgens.
Sonnenschein C; Olea N; Pasanen ME; Soto AM
Cancer Res; 1989 Jul; 49(13):3474-81. PubMed ID: 2731169
[TBL] [Abstract][Full Text] [Related]
39. Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate.
Scarano WR; Vilamaior PS; Taboga SR
Anat Rec A Discov Mol Cell Evol Biol; 2006 Nov; 288(11):1190-200. PubMed ID: 17031809
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time.
Sorenmo KU; Goldschmidt M; Shofer F; Goldkamp C; Ferracone J
Vet Comp Oncol; 2003 Mar; 1(1):48-56. PubMed ID: 19379330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
